{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:29:55Z","timestamp":1784327395726,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009048","name":"Japanese Society of Clinical Neuropsychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ajp.2021.102935","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T20:44:48Z","timestamp":1637613888000},"page":"102935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey"],"prefix":"10.1016","volume":"67","author":[{"given":"Masataka","family":"Shinozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Yasui-Furukori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Azekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihisa","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Katsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Edagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhira","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiji","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2021.102935_bib1","article-title":"Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients\u2019 and practitioners\u2019 parameters in the MUSUBI study","author":"Adachi","year":"2020","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102935_bib2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1176\/appi.ajp.2009.09020284","article-title":"Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study","volume":"167","author":"Amsterdam","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1192\/bjp.bp.115.169375","article-title":"Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate","volume":"208","author":"Amsterdam","year":"2016","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"key":"10.1016\/j.ajp.2021.102935_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"Association, American Psychiatric","year":"2013"},{"key":"10.1016\/j.ajp.2021.102935_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2010.11.020","article-title":"Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history","volume":"131","author":"Baek","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ajp.2021.102935_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1176\/ps.2007.58.1.85","article-title":"Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders","volume":"58","author":"Baldessarini","year":"2007","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.ajp.2021.102935_bib7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: a systematic review and meta-analysis of the literature","volume":"37","author":"Clemente","year":"2015","journal-title":"Rev. Bras. De. Psiquiatr."},{"key":"10.1016\/j.ajp.2021.102935_bib9","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(15)00241-X","article-title":"Bipolar disorder","volume":"387","author":"Grande","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2021.102935_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/nyas.13048","article-title":"Innovative approaches to bipolar disorder and its treatment","volume":"1366","author":"Harrison","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ajp.2021.102935_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/pcn.12060","article-title":"Guideline for treatment of bipolar disorder by the Japanese society of mood disorders, 2012","volume":"67","author":"Kanba","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2021.102935_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bdi.12867","article-title":"Characteristics of bipolar I and II disorder: a study of 8766 individuals","volume":"22","author":"Karanti","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2021.102935_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpsychires.2020.09.030","article-title":"Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: a multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI)","volume":"131","author":"Kato","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ajp.2021.102935_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib16","article-title":"National institute for health and care excellence: clinical guidelines, bipolar disorder: the NICE Guideline on the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care","volume":"2014","author":"National Collaborating Centre for Mental, H","year":"2014","journal-title":"Br. Psychol. Soc. R. Coll. Psychiatr. \u00a9 Br. Psychol. Soc. R. Coll. Psychiatr."},{"key":"10.1016\/j.ajp.2021.102935_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.64.4.442","article-title":"Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Scherk","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0447.2006.00912.x","article-title":"Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy","volume":"115","author":"Smith","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2021.102935_bib19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","article-title":"Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study)","volume":"26","author":"Thase","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2021.102935_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12888-020-02967-5","article-title":"Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder","volume":"20","author":"Tokumitsu","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2147\/NDT.S246136","article-title":"Factors associated with non-remission in bipolar disorder: the multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI)","volume":"16","author":"Tsuboi","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ajp.2021.102935_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.108.057612","article-title":"Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review","volume":"196","author":"Van Lieshout","year":"2010","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"key":"10.1016\/j.ajp.2021.102935_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0010-440X(97)90088-2","article-title":"Differential features between bipolar I and bipolar II disorder","volume":"38","author":"Vieta","year":"1997","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.ajp.2021.102935_bib25","series-title":"International Classification of Diseases and Related Health Problems, 10th revision","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.ajp.2021.102935_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.9758\/cpn.2020.18.4.599","article-title":"Factors associated with doses of mood stabilizers in real-world outpatients with bipolar disorder","volume":"18","author":"Yasui-Furukori","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci.: Off. Sci. J. Korean Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2021.102935_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar disord."},{"key":"10.1016\/j.ajp.2021.102935_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2021.102935_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00004714-199312000-00005","article-title":"Treatment of depression in bipolar disorder: new directions for research","volume":"13","author":"Zornberg","year":"1993","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821003919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201821003919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:40:55Z","timestamp":1761756055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201821003919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"alternative-id":["S1876201821003919"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102935","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2021.102935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102935"}}